Alex Kotzer
Keine laufenden Positionen mehr
Profil
Mr. Alex Kotzer is Chairman & Chief Executive Officer at Regenera Pharma Ltd.
He is on the Board of Directors at Compugen Ltd.
He received his undergraduate degree from the Technion-Israel Institute of Technology.
Ehemalige bekannte Positionen von Alex Kotzer
| Unternehmen | Position | Ende |
|---|---|---|
Regenera Pharma Ltd.
 Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Vorstandsvorsitzender | - |
| COMPUGEN LTD. | Präsident | 03.06.2009 |
Ausbildung von Alex Kotzer
| Technion-Israel Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Health Technology |
